Unable to load price data. Sorry.

¯\_(ツ)_/¯

Marina Biotech Inc (NASDAQOTH:MRNA.DL)

CAPS Rating: No stars

A pharmaceutical company, which is focusing on development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology for delivering both small and large molecule drugs.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQOTH:MRNA.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

blaster888 (78.12)
Submitted December 13, 2006

Large pipeline of drugs, deal with PG, cash on hand and no debt. Novel delivery system. Potentially huge patent covering analogs of Peptide YY, or peptide derivatives, in the fields of obesity, so that anyone that makes a deal using PYY will have to… More

JDSancho (99.70)
Submitted June 19, 2008

This Minyanville article sums up my feelings on MDRNA...I mean...Nastech...no, I was right, MDRwhocares. http://www.minyanville.com/articles/MRK-amgn-IMCL-CTIC-ALNY-MRNA/index/a/17562/from/yahooThis company plays perfectly into my "underperform due… More

NASDAQOTH:MRNA.DL VS S&P 500 (SPY)

NASDAQOTH:MRNA.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about MRNA.DL.

No one has written a Pitch for MRNA.DL stock yet. Tell us why you think MRNA.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in MRNA.DL.

No players have picked MRNA.DL yet. Tell us why you think MRNA.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 86.25 3/16/2007 Outperform 3W $392.40 -99.89% +107.77% -207.65 10/9/2018 @ $0.45 0 Comment
TrackRodmanRen < 20 1/5/2007 Outperform NS $587.20 -82.56% -7.05% -75.51 3/12/2008 @ $102.40 0 Comment
TrackWedbush 88.31 12/14/2006 Outperform NS $650.00 -99.93% +102.89% -202.82 10/9/2018 @ $0.45 0 Comment
TrackNeedham 88.67 11/20/2006 Outperform NS $768.40 -99.11% -5.13% -93.98 3/31/2011 @ $6.84 0 Comment

Advertisement